Deletion of the CCK2 receptor gene reduces mechanical sensitivity and abolishes the development of hyperalgesia in mononeuropathic mice

No abstract is available for this paper.

• Publication year

  2004

• Venue

  European Journal of Neuroscience

• Publication date

  2004-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1460-9568.2004.03619.xPMID 15355324
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Behavioral alterations induced by repeated testing in C57BL/6J and 129S2/Sv mice: implications for phenotyping screens

  2004cited by this paper
• Cholecystokinin blockade alters the systemic immune response in rats with acute pancreatitis

  2004cited by this paper
• Prostaglandins mediate lipopolysaccharide effects upon cholecystokinin and neurotensin phenotypes in neuroendocrine corticotropin-releasing hormone neurons: in situ hybridization evidence in the rat.

  2003cited by this paper
• Altered pain sensitivity and morphine-induced anti-nociception in mice lacking CCK2 receptors

  2003cited by this paper
• Deletion of CCK2 Receptor in Mice Results in an Upregulation of the Endogenous Opioid System

  2002cited by this paper
• Selective depression of nociceptive responses of dorsal horn neurones by SNC 80 in a perfused hindquarter preparation of adult mouse.

  2001cited by this paper
• Supraspinal cholecystokinin may drive tonic descending facilitation mechanisms to maintain neuropathic pain in the rat

  2000cited by this paper
• International Union of Pharmacology. XXI. Structure, distribution, and functions of cholecystokinin receptors.

  1999cited by this paper
• Heritability of nociception I: responses of 11 inbred mouse strains on 12 measures of nociception.

  1999cited by this paper
• CCK-B receptor: chemistry, molecular biology, biochemistry and pharmacology.

  1999cited by this paper
• Modulation of murine lymphocyte functions by sulfated cholecystokinin octapeptide.

  1998cited by this paper
• mRNAs encoding CCKB but not CCKA receptors are expressed in human T lymphocytes and Jurkat lymphoblastoid cells.

  1997cited by this paper
• Antiallodynic effects of a CCKB antagonist in rats with nerve ligation injury: role of endogenous enkephalins.

  1996cited by this paper
• G protein-coupled cholecystokinin-B/gastrin receptors are responsible for physiological cell growth of the stomach mucosa in vivo.

  1996cited by this paper
• A selective CCKB receptor antagonist potentiates μ-, but not δ-opioid receptor-mediated antinociception in the formalin test

  1995cited by this paper
• Role of cholecystokinin-B receptor in the maintenance of thermal hyperalgesia induced by unilateral constriction injury to the sciatic nerve in the rat.

  1995cited by this paper
• A selective CCKB receptor antagonist potentiates, mu-, but not delta-opioid receptor-mediated antinociception in the formalin test.

  1995cited by this paper
• Quantitative assessment of tactile allodynia in the rat paw.

  1994cited by this paper
• Cholecystokinin and morphine analgesia: variations on a theme.

  1994cited by this paper
• Antisense oligodeoxynucleotide to the CCKB receptor produces naltrindole- and [Leu5]enkephalin antiserum-sensitive enhancement of morphine antinociception.

  1994cited by this paper
• Differential effects of specific δ and κ opioid receptor antagonists on the bidirectional dose-dependent effect of systemic naloxone in arthritic rats, an experimental model of persistent pain

  1993cited by this paper
• Differential effects of specific delta and kappa opioid receptor antagonists on the bidirectional dose-dependent effect of systemic naloxone in arthritic rats, an experimental model of persistent pain.

  1993cited by this paper
• Up-regulation of cholecystokinin in primary sensory neurons is associated with morphine insensitivity in experimental neuropathic pain in the rat.

  1993cited by this paper
• Regulation of human T lymphoblast growth by sensory neuropeptides: augmentation of cholecystokinin-induced inhibition of Molt-4 proliferation by somatostatin and vasoactive intestinal peptide in vitro.

  1992cited by this paper
• The CCK-A and CCK-B receptor antagonists, devazepide and L-365,260, enhance morphine antinociception only in non-acclimated rats exposed to a novel environment.

  1992cited by this paper
• Trigeminal and dorsal root ganglion neurons express CCK receptor binding sites in the rat, rabbit, and monkey: possible site of opiate- CCK analgesic interactions

  1992cited by this paper
• Visualization of cholecystokinin receptors on a subset of human monocytes and in rat spleen.

  1991cited by this paper
• Effect of cholecystokinin receptor blockade on human lymphocyte proliferation.

  1990cited by this paper
• The nature of opioid responsiveness and its implications for neuropathic pain: new hypotheses derived from studies of opioid infusions

  1990cited by this paper
• Effects of iontophoresed opioids on physiologically characterized laminae I and II dorsal horn neurons in the cat spinal cord.

  1990cited by this paper
• The role of CCK, caerulein, and CCK antagonists in nociception

  1989cited by this paper
• A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man

  1988cited by this paper
• The influence of opioid receptor subtypes on the processing of nociceptive inputs in the spinal dorsal horn of the cat.

  1988cited by this paper
• Opiate Antagonistic Function of Cholecystokinin in Analgesia and Energy Balance Systems a

  1985cited by this paper
• Evidence for the neuropeptide cholecystokinin as an antagonist of opiate analgesia.

  1983cited by this paper
• Morphine depresses dorsal horn neuron responses to controlled noxious and non-noxious cutaneous stimulation.

  1980cited by this paper
• Differential excitatory and inhibitory effects of opiates on non-nociceptive and nociceptive neurones in the spinal cord of the cat.

  1978cited by this paper
• ENKEPHALINS AND DORSAL HORN NEURONES OF THE CAT: EFFECTS ON RESPONSES TO NOXIOUS AND INNOCUOUS SKIN STIMULI

  1977cited by this paper

• Bivalent and bitopic ligands of the opioid receptors: The prospects of a dual approach

  2024cites this paper
• Deterioration of apatite orientation in the cholecystokinin B receptor gene (Cckbr)-deficient mouse femurs

  2023cites this paper
• CCK-8 enhances acid-sensing ion channel currents in rat primary sensory neurons.

  2023cites this paper
• The Cholecystokinin Type 2 Receptor, a Pharmacological Target for Pain Management

  2021influential citation
• Role of Spinal Cord Akt-mTOR Signaling Pathways in Postoperative Hyperalgesia Induced by Plantar Incision in Mice

  2020cites this paper
• Contribution of Histamine to Nociceptive Behaviors Induced by Intrathecally Administered Cholecystokinin-8

  2020cites this paper
• Cholecystokinin type B receptor-mediated inhibition of A-type K+ channels enhances sensory neuronal excitability through the phosphatidylinositol 3-kinase and c-Src-dependent JNK pathway

  2019cites this paper
• Investigating mechanisms of pain in Alzheimer's disease

  2018cites this paper
• Effects of Transcranial Direct Current Stimulation, Transcranial Pulsed Current Stimulation, and Their Combination on Brain Oscillations in Patients with Chronic Visceral Pain: A Pilot Crossover Randomized Controlled Study

  2017cites this paper
• MCP‐1‐mediated activation of microglia promotes white matter lesions and cognitive deficits by chronic cerebral hypoperfusion in mice

  2017cites this paper
• A pharmacological and transcriptomic approach to exploring novel pain targets

  2016cites this paper
• Transcriptomic and behavioural characterisation of a mouse model of burn pain identify the cholecystokinin 2 receptor as an analgesic target

  2016cites this paper
• Reduced thermal sensitivity and increased opioidergic tone in the TASTPM mouse model of Alzheimer's disease

  2016cites this paper
• Stress-induced hyperalgesia.

  2014cites this paper
• Behavioural, pharmacological and neurochemical characterization of limbic system-associated membrane protein (LSAMP) deficient mice

  2013cites this paper
• Similarity and difference of temperature-dependence of the brain sodium pump in normal, different neuropathological, and aberrant conditions and its possible reasons

  2011cites this paper
• Lower anxiety and a decrease in agonistic behaviour in Lsamp-deficient mice.

  2011cites this paper
• Formalin-induced long-term secondary allodynia and hyperalgesia are maintained by descending facilitation.

  2011cites this paper
• Temperature Dependence of the Sodium Pump is Altered in the Cerebral Cortex of CCK2 Receptor-Deficient Mice

  2010cites this paper
• Role of spinal cholecystokinin in neuropathic pain after spinal cord hemisection in rats.

  2009cites this paper
• Induced association of mu opioid (MOP) and type 2 cholecystokinin (CCK2) receptors by novel bivalent ligands.

  2009cites this paper
• Environmental enrichment reduces mechanical hypersensitivity in neuropathic mice, but fails to abolish the phenotype of CCK2 receptor deficient mice.

  2009cites this paper
• Local peripheral opioid effects and expression of opioid genes in the spinal cord and dorsal root ganglia in neuropathic and inflammatory pain

  2009cites this paper
• Modulation des systèmes opioïdes par des neuropeptides endogènes (CCK, NPFF, opioïde)

  2009cites this paper
• Stress‐induced analgesia in mice: evidence for interaction between endocannabinoids and cholecystokinin

  2008cites this paper
• Gene expression profiling reveals upregulation of Tlr4 receptors in Cckb receptor deficient mice.

  2008cites this paper
• Pain pharmacology and analgesia

  2008cites this paper
• Pro-nociceptive action of cholecystokinin in the periaqueductal grey: a role in neuropathic and anxiety-induced hyperalgesic states.

  2008cites this paper
• Sex and environmental factors determine the behavioural phenotype of mice lacking CCK2 receptors: implications for the behavioural studies in transgenic lines

  2008cites this paper
• Different housing conditions alter the behavioural phenotype of CCK(2) receptor-deficient mice.

  2008cites this paper
• Altered renal morphology in transgenic mice with cholecystokinin overexpression

  2008influential citation
• Interpretation of knockout experiments: the congenic footprint

  2007influential citation
• CCK2 retseptori geneetiline väljalülitamine kutsub emastel hiirtel esile GABAergilise süsteemi aktiivsuse muutused ajus

  2007cites this paper
• Transgenic models of pain: a brief review.

  2006cites this paper
• CCK2 retseptori geneetiline väljalülitamine ei mõjuta hiirte õppimisvõimet Morrise vesipuuris ja passiivse vältimise katses

  2006cites this paper
• Behavioural and neurogenetic study of molecular mechanisms involved in regulation of exploratory behaviour in rodents

  2006cites this paper
• Very low levels of cholecystokinin octapeptide activate Na‐pump in the cerebral cortex of CCK2 receptor‐deficient mice

  2006cites this paper
• Endogenous opiates and behavior: 2004.

  2005cites this paper
• Cholecystokinin2 receptor deficient mice: changes in function of GABA-ergic system

  2005cites this paper